Back
Catalyst Pharmaceuticals Stock Predictions
This New Idea is Set to Shock the World
Click here to learn all the details.
Buy
56
CPRX
Catalyst Pharmaceuticals
Last Price:
15.82
Seasonality Move:
34.21%
7 Day Trial
ALL ACCESS PASS
$
7
Free video reveals how to trade 1-day options
Get the free overnight options training here.Catalyst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 40.9% based on the past 17 years of stock performance.
- Catalyst Pharmaceuticals has risen higher in 13 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.47%
-
Is Catalyst Pharmaceuticals Stock Undervalued?
The current Catalyst Pharmaceuticals [CPRX] share price is $15.77. The Score for CPRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. - CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 40.9% based on the past 17 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Buy
56
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals overpriced?
- Catalyst Pharmaceuticals has risen higher in 13 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.47%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
17.50
52-Week Low:
11.55
Prediction Charts
Market Cap:
1.86B
Price in USD:
15.77
Volume:
835.74K
Beta:
1.10
Technical Analysis
SMA50:
15.58
SMA100:
15.45
SMA200:
14.62
52-Wk Change:
17.34%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?
Yes, Catalyst Pharmaceuticals is a publicly traded company. -
What is the Catalyst Pharmaceuticals stock quote today?
The Catalyst Pharmaceuticals stock price is 15.77 USD today. -
How to buy Catalyst Pharmaceuticals stock online?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-11 | 15.50 | 15.56 | 15.61 | 15.19 |
| Jun-12 | 15.94 | 15.43 | 15.97 | 15.38 |
| Jun-13 | 15.35 | 15.33 | 15.50 | 15.17 |
| Jun-14 | 15.13 | 15.06 | 15.25 | 14.95 |
| Jun-17 | 15.00 | 15.00 | 15.20 | 14.76 |
| Jun-18 | 15.00 | 14.97 | 15.05 | 14.78 |
| Jun-20 | 14.88 | 15.18 | 15.26 | 14.76 |
| Jun-21 | 15.26 | 15.59 | 15.72 | 15.04 |
| Jun-24 | 15.64 | 15.39 | 15.93 | 15.38 |
| Jun-25 | 15.42 | 15.15 | 15.43 | 15.15 |
| Jun-26 | 15.05 | 15.08 | 15.12 | 14.75 |
| Jun-27 | 15.12 | 15.04 | 15.18 | 14.96 |
| Jun-28 | 15.18 | 15.49 | 15.52 | 15.04 |
| Jul-1 | 15.52 | 15.77 | 15.97 | 15.49 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.